Peter J. Houghton

Phosphorylation of the Translational Repressor PHAS-I by the Mammalian Target of Rapamycin

Gregory J. Brunn, Christine C. Hudson, Aleksandar Sekulić et al. · Science · 1997 · 960 citations

Life Sciences, Cell Biology, Molecular Biology +17

A selective BCL-XL PROTAC degrader achieves safe and potent antitumor activity

Sajid Khan, Xuan Zhang, Dongwen Lv et al. · Nature Medicine · 2019 · 647 citations · Full text

Medicine, Oncology, Pharmacology +7

Establishment of human tumor xenografts in immunodeficient mice

Christopher L. Morton, Peter J. Houghton · Nature Protocols · 2007 · 486 citations

Medicine, Immunology, Oncology +4

The pediatric preclinical testing program: Description of models and early testing results

Peter J. Houghton, Christopher L. Morton, Chandra L. Tucker et al. · Pediatric Blood & Cancer · 2006 · 483 citations

Medicine, Oncology, Cancer Pharmacology +14

In-vitro Inhibition of Human Erythrocyte Acetylcholinesterase by <i>Salvia lavandulaefolia</i> Essential Oil and Constituent Terpenes

Nicolette S L Perry, Peter J. Houghton, A.E. Theobald et al. · Journal of Pharmacy and Pharmacology · 2000 · 452 citations · Full text

Medicine, Biochemistry, Pharmacology +13